Objectives: Endoscopic ultrasound (EUS) fine needle aspiration (FNA) biopsies are commonly used to diagnose tumors of the pancreas. Serous cystadenoma (SCA) is a benign neoplasm that is uncommon and accounts for 1-2% of all pancreatic neoplasms. Study Design: Surgically excised SCAs with preoperative EUS FNA biopsy over a 10-year span were identified. Clinical data were collected, and cytomorphologic features reviewed retrospectively and correlated with surgical excision data. Original cytopathologic diagnoses and retrospectively reviewed cytomorphology features were recorded. Results: Seventeen patients were identified. Original EUS FNA interpretation included 1 ‘unsatisfactory', 9 ‘negative for malignancy' and 7 ‘atypical' or greater; however, all cases were categorized as benign/negative or nondiagnostic on retrospective review. The cases were hypocellular and possessed variable (rare to few-moderate) groups of bland cuboidal epithelial cells embedded in granular debris. Mucosal sampling was present (7/17) and cell blocks were acellular (5/17). Conclusion: This is a large series of pancreas SCAs subjected exclusively to EUS FNA biopsy where all cases had surgical excision confirmation. The 17 cases had hypocellular aspirate smears with the majority showing few bland epithelial cells; however, this can limit definitive diagnosis based on the cytomorphologic evaluation alone. The aspirate smear pattern of EUS FNA of SCAs of the pancreas supports a benign/negative or nondiagnostic categorization.

1.
Kosmahl M, Pauser U, Peters K, Sipos B, Luttges J, Kremer B, Kloppel G: Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch 2004;445:168-178.
2.
Colonna J, Plaza JA, Frankel WL, Yearsley M, Bloomston M, Marsh WL: Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients. Pancreatology 2008;8:135-141.
3.
Compagno J, Oertel JE: Microcystic adenomas of the pancreas (glycogen-rich cystadenomas): a clinicopathologic study of 34 cases. Am J Clin Pathol 1978;69:289-298.
4.
Garcea G, Ong SL, Rajesh A, Neal CP, Pollard CA, Berry DP, Dennison AR: Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology 2008;8:236-251.
5.
Kim HJ, Lee DH, Ko YT, Lim JW, Kim HC, Kim KW: CT of serous cystadenoma of the pancreas and mimicking masses. AJR Am J Roentgenol 2008;190:406-412.
6.
Jones EC, Suen KC, Grant DR, Chan NH: Fine-needle aspiration cytology of neoplastic cysts of the pancreas. Diagn Cytopathol 1987;3:238-243.
7.
Hittmair A, Pernthaler H, Totsch M, Schmid KW: Preoperative fine needle aspiration cytology of a microcystic adenoma of the pancreas. Acta Cytol 1991;35:546-548.
8.
Young NA, Villani MA, Khoury P, Naryshkin S: Differential diagnosis of cystic neoplasms of the pancreas by fine-needle aspiration. Arch Pathol Lab Med 1991;115:571-577.
9.
Laucirica R, Schwartz MR, Ramzy I: Fine needle aspiration of pancreatic cystic epithelial neoplasms. Acta Cytol 1992;36:881-886.
10.
Nguyen GK, Vogelsang PJ: Microcystic adenoma of the pancreas. A report of two cases with fine needle aspiration cytology and differential diagnosis. Acta Cytol 1993;37:908-912.
11.
Centeno BA, Lewandrowski KB, Warshaw AL, Compton CC, Southern JF: Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions. Am J Clin Pathol 1994;101:483-487.
12.
Centeno BA, Warshaw AL, Mayo-Smith W, Southern JF, Lewandrowski K: Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates. Acta Cytol 1997;41:972-980.
13.
Nguyen GK, Suen KC, Villanueva RR: Needle aspiration cytology of pancreatic cystic lesions. Diagn Cytopathol 1997;17:177-182.
14.
Logrono R, Vyas SH, Molina CP, Waxman I: Microcystic adenoma of the pancreas: cytologic appearance on percutaneous and endoscopic ultrasound-guided fine-needle aspiration: report of a case. Diagn Cytopathol 1999;20:298-301.
15.
Rampy BA, Waxman I, Xiao SY, Logrono R: Serous cystadenoma of the pancreas with papillary features: a diagnostic pitfall on fine-needle aspiration biopsy. Arch Pathol Lab Med 2001;125:1591-1594.
16.
Lal A, Bourtsos EP, DeFrias DV, Nemcek AA, Nayar R: Microcystic adenoma of the pancreas: clinical, radiologic, and cytologic features. Cancer 2004;102:288-294.
17.
Huang P, Staerkel G, Sneige N, Gong Y: Fine-needle aspiration of pancreatic serous cystadenoma: cytologic features and diagnostic pitfalls. Cancer 2006;108:239-249.
18.
Delatour NR, Policarpio-Nicolas ML, Yazdi H, Islam S: Fine needle aspiration biopsy for preoperative workup of pancreatic cystic neoplasms: report of 4 cases. Acta Cytol 2007;51:925-933.
19.
Moparty B, Logrono R, Nealon WH, Waxman I, Raju GS, Pasricha PJ, Bhutani MS: The role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in distinguishing pancreatic cystic lesions. Diagn Cytopathol 2007;35:18-25.
20.
Belsley NA, Pitman MB, Lauwers GY, Brugge WR, Deshpande V: Serous cystadenoma of the pancreas: limitations and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2008;114:102-110.
21.
Fitzhugh VA, Mirani N, Aisner S, Koneru B, Das K: Preoperative fine needle aspiration cytology diagnosis of microcystic adenoma of the pancreas: fact or fiction? A report of 2 cases. Acta Cytol 2008;52:240-246.
22.
Houlton JJ, Sun GH, Fernandez N, Zhai QJ, Lucas F, Steward DL: Thyroid fine-needle aspiration: does case volume affect diagnostic yield and interpretation? Arch Otolaryngol Head Neck Surg 2011;137:1136-1139.
23.
Gupta PK: Progression from on-site to point-of-care fine needle aspiration service: opportunities and challenges. Cytojournal 2010;7:6.
24.
Schmidt RL, Witt BL, Matynia AP, Barraza G, Layfield LJ, Adler DG: Rapid on-site evaluation increases endoscopic ultrasound-guided fine-needle aspiration adequacy for pancreatic lesions. Dig Dis Sci 2012, E-pub ahead of print.
25.
Wargo JA, Fernandez-del-Castillo C, Warshaw AL: Management of pancreatic serous cystadenomas. Adv Surg 2009;43:23-34.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.